Monetary Management Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122K Buy
2,860
+1,000
+54% +$54.3K 0.03% 229
2026
Q1
$117K Sell
1,860
-2,400
-56% -$192K 0.03% 227
2025
Q4
$406K Buy
4,260
+900
+27% +$88.2K 0.09% 162
2025
Q3
$328K Buy
3,360
+1,000
+42% +$104K 0.08% 174
2025
Q2
$253K Hold
2,360
– – 0.06% 184
2025
Q1
$238K Sell
2,360
-500
-17% -$50.3K 0.06% 188
2024
Q4
$255K Buy
+2,860
New +$252K 0.07% 184

Other funds holding BSX

Monetary Management Group's BSX Position: Q2 2026 in Review

Monetary Management Group increased its Boston Scientific (BSX) stake by 54% in Q2 2026, buying an estimated $54.3K and bringing the position to 2,860 shares worth $122K. The position accounts for 0.03% of the portfolio, ranked #229.

Monetary Management Group first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $406K in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Monetary Management Group held 2,860 shares of Boston Scientific worth $122K as of Q2 2026.
  • Monetary Management Group bought 1,000 Boston Scientific shares in Q2 2026, an estimated $54.3K.
  • Boston Scientific made up 0.03% of Monetary Management Group's portfolio in Q2 2026, its #229 holding.
  • Monetary Management Group first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Monetary Management Group's Boston Scientific position peaked at $406K in Q4 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Monetary Management Group's 13F filing for Q2 2026, filed 12 Aug 2026.